Early Estimate of Nirsevimab Effectiveness for Prevention of Respiratory Syncytial Virus–Associated Hospitalization Among Infants Entering Their First Respiratory Syncytial Virus Season — New Vaccine Surveillance Network, October 2023–February 2024 | M - CDC


3/7/2024

Early Estimate of Nirsevimab Effectiveness for Prevention of Respiratory Syncytial Virus–Associated Hospitalization Among Infants Entering Their First Respiratory Syncytial Virus Season — New Vaccine Surveillance Network, October 2023–February 2024 | M  CDCRSV monoclonal Beyfortus was 90% effective at preventing hospitalizations in children this winter: CDC  STATOnly nine percent of older Americans were vaccinated against RSV before the disease hit this fall and winter  Medical XpressRSV shot for infants 90 percent effective against hospitalizations: CDC  Yahoo! VoicesCDC says new treatment for infant RSV infections ‘highly effective’ in preventing hospitalization  WSB Atlanta...

Original



Let us know what you think!

Click on a star to rate it!

Average rating 0 / 5. Vote count: 0

No votes so far! Be the first to rate this post.

Leave a Comment

Scroll back to top